Community Intervention to Reduce Tobacco Use in Pregnant Women (Sisters)
Primary Purpose
Nicotine Dependence
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Community level intervention
Sponsored by
About this trial
This is an interventional treatment trial for Nicotine Dependence focused on measuring tobacco, smoking
Eligibility Criteria
Inclusion Criteria:
- Alaska Native
- >18 years of age
- able to provide written informed consent
- currently pregnant and at < 26 weeks gestation
- has access to a working telephone.
Exclusion Criteria:
- plans to have an abortion
Sites / Locations
- Yukon Kuskokwim Health Corporation
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
community intervention
usual care
Arm Description
Community level intervention (Social marketing campaign delivered to entire village) plus individual peer counseling sessions for enrolled pregnant women
Usual care provided by health aides to pregnant women
Outcomes
Primary Outcome Measures
Number of Participants With Tobacco Abstinence at 6-months Post-partum
Total number of participants to have biochemically confirmed tobacco abstinence at 6-months post-partum
Number of Participants With Tobacco Abstinence at End of Pregnancy
Total number of participants to have biochemically confirmed tobacco abstinence at end of pregnancy (delivery).
Secondary Outcome Measures
Change in Self-efficacy for Non-tobacco Use Scores
Change from baseline in self-efficacy for non-tobacco use scores measured by the self-reported Smoking Confidence Questionnaire. Total scores range from 0-30, higher scores indicate better outcome.
Full Information
NCT ID
NCT02083081
First Posted
March 5, 2014
Last Updated
June 22, 2022
Sponsor
Mayo Clinic
Collaborators
Yukon Kuskokwim Health Corporation, University of Minnesota, National Cancer Institute (NCI)
1. Study Identification
Unique Protocol Identification Number
NCT02083081
Brief Title
Community Intervention to Reduce Tobacco Use in Pregnant Women
Acronym
Sisters
Official Title
Community Intervention to Reduce Tobacco Use Among Alaska Native Pregnant Women
Study Type
Interventional
2. Study Status
Record Verification Date
June 2022
Overall Recruitment Status
Completed
Study Start Date
May 2014 (Actual)
Primary Completion Date
December 2020 (Actual)
Study Completion Date
December 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mayo Clinic
Collaborators
Yukon Kuskokwim Health Corporation, University of Minnesota, National Cancer Institute (NCI)
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
In the southwest region of Alaska where the project takes place, 79% of Alaska Native women smoke cigarettes or use smokeless tobacco (ST) during pregnancy. In addition, pregnancy appears to be a high risk period for initiation of tobacco use, primarily ST, among women reporting no use of tobacco 3 months before pregnancy. Intervention efforts targeting the entire community, not only pregnant women, to address social norms about tobacco use may be effective. Thus, the investigators will evaluate the efficacy of a novel, multi-component, theory-based intervention for reducing tobacco use during pregnancy, incorporating both individually targeted and community level components delivered by female elders "Native Sisters." The intervention builds on effective community and individual-based approaches for tobacco cessation and lay health advisor approaches for cancer prevention among Native American women. As part of the intervention, a social marketing campaign including digital stories and other small media will be developed with community feedback. Individually targeted components will be six 30-40 minute telephone or home-based peer counseling sessions with pregnant women.
Detailed Description
The project will be conducted in two phases. In Phase I, the investigators will develop the social marketing components by obtaining qualitative feedback from pregnant women, family members and elders on message content and delivery channels. In Phase II, the investigators will evaluate the intervention using a group-randomized design with village as the unit of assignment. Sixteen villages will be randomly assigned to receive the intervention or control condition (usual care), with > 20 pregnant women enrolled from each village. Assessments will be completed by enrolled women through 6 months postpartum. All aspects of the project will be guided by a Community Advisory Committee.
The Specific Aims are:
Aim 1. To develop and pre-test the social marketing campaign messages and delivery channels through focus groups and individual interviews of pregnant women, family members, and elders. The focus group work will assess reasons for initiating or continuing tobacco use during pregnancy and the potential role of other community members in addressing tobacco use in pregnancy. Findings will be used to develop campaign messages and media that will be pre-tested through individual interviews and refined. Session content for the individually targeted intervention components will also be developed to align with the campaign messages.
Aim 2. To evaluate the efficacy of the intervention compared with the control condition on the biochemically confirmed 7-day point prevalence tobacco use rate at week 36 gestation and at 6 months postpartum.
Hypothesis: Compared with the control condition, the intervention will be associated with significantly lower rates of tobacco use in late pregnancy (80% vs. 65%) and at 6 months postpartum (70% vs. 55%).
Aim 3. To examine the effect of the intervention on proposed social cognitive-theory based mediators of change including perceived social norms about tobacco use and self-efficacy for non-tobacco use.
Hypothesis: Intervention effects on tobacco use at week 36 gestation and at 6 months postpartum will be mediated by perceived self-efficacy and anti-tobacco norms.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nicotine Dependence
Keywords
tobacco, smoking
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
352 (Actual)
8. Arms, Groups, and Interventions
Arm Title
community intervention
Arm Type
Experimental
Arm Description
Community level intervention (Social marketing campaign delivered to entire village) plus individual peer counseling sessions for enrolled pregnant women
Arm Title
usual care
Arm Type
No Intervention
Arm Description
Usual care provided by health aides to pregnant women
Intervention Type
Behavioral
Intervention Name(s)
Community level intervention
Intervention Description
Community intervention plus individual counseling
Primary Outcome Measure Information:
Title
Number of Participants With Tobacco Abstinence at 6-months Post-partum
Description
Total number of participants to have biochemically confirmed tobacco abstinence at 6-months post-partum
Time Frame
6 months postpartum
Title
Number of Participants With Tobacco Abstinence at End of Pregnancy
Description
Total number of participants to have biochemically confirmed tobacco abstinence at end of pregnancy (delivery).
Time Frame
Approximately 9 months
Secondary Outcome Measure Information:
Title
Change in Self-efficacy for Non-tobacco Use Scores
Description
Change from baseline in self-efficacy for non-tobacco use scores measured by the self-reported Smoking Confidence Questionnaire. Total scores range from 0-30, higher scores indicate better outcome.
Time Frame
Baseline, 6 months postpartum
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Alaska Native
>18 years of age
able to provide written informed consent
currently pregnant and at < 26 weeks gestation
has access to a working telephone.
Exclusion Criteria:
plans to have an abortion
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christi A Patten, PhD
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Yukon Kuskokwim Health Corporation
City
Bethel
State/Province
Alaska
ZIP/Postal Code
99559
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Links:
URL
https://www.mayo.edu/research/clinical-trials
Description
Mayo Clinic Clinical Trials
Learn more about this trial
Community Intervention to Reduce Tobacco Use in Pregnant Women
We'll reach out to this number within 24 hrs